Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 375 Neoplasms 325 Neoplasm Metastasis 290 Leukemia, Myeloid, Acute 282 Breast Neoplasms 277 Colorectal Neoplasms 239 Melanoma 197 Ovarian Neoplasms 193 Recurrence 187 Multiple Myeloma 181 Prostatic Neoplasms 157 Pancreatic Neoplasms 156 Lung Neoplasms 156 Squamous Cell Carcinoma of Head and Neck 150 Lymphoma, Non-Hodgkin 146 Glioblastoma 145 Triple Negative Breast Neoplasms 120 Myelodysplastic Syndromes 117 Carcinoma, Renal Cell 111 Stomach Neoplasms 110 Glioma 108 Advanced Solid Tumors 108 Brain Neoplasms 105 Precursor Cell Lymphoblastic Leukemia-Lymphoma 104 Lymphoma 103 Lymphoma, Large B-Cell, Diffuse 102 Lymphoma, B-Cell 98 Carcinoma, Hepatocellular 95 Endometrial Neoplasms 92 Lymphoma, Follicular 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Malignant Ascites × 1 year × Clear all

NCT07007988 2025-06-06

SIM0388-101

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting

Malignant Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡